Sera Prognostics, Inc. (SERA)
2.01
+0.03
(+1.52%)
USD |
NASDAQ |
Nov 13, 16:00
2.00
-0.01
(-0.50%)
After-Hours: 19:59
Sera Prognostics Net Income (Quarterly) : -8.053M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -8.053M |
| June 30, 2026 | -9.139M |
| March 31, 2026 | -8.399M |
| December 31, 2025 | -7.881M |
| September 30, 2025 | -7.814M |
| June 30, 2025 | -8.046M |
| March 31, 2025 | -8.187M |
| December 31, 2024 | -8.579M |
| September 30, 2024 | -7.919M |
| June 30, 2024 | -8.303M |
| March 31, 2024 | -8.097M |
| December 31, 2023 | -7.925M |
| September 30, 2023 | -7.21M |
| June 30, 2023 | -10.54M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.56M |
| December 31, 2022 | -9.746M |
| September 30, 2022 | -10.71M |
| June 30, 2022 | -11.52M |
| March 31, 2022 | -12.21M |
| December 31, 2021 | -12.48M |
| September 30, 2021 | -9.859M |
| June 30, 2021 | -6.307M |
| March 31, 2021 | -6.359M |
| December 31, 2020 | -5.375M |
| September 30, 2020 | -5.072M |
| June 30, 2020 | -4.705M |
| March 31, 2020 | -4.696M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -43.90M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 19.29M |
| Natera, Inc. | -59.91M |
| Exagen, Inc. | -6.336M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.042M |
| Total Expenses (Quarterly) | 8.095M |
| EPS Diluted (Quarterly) | -0.1586 |
| Enterprise Value | 39.06M |
| Gross Profit Margin (Quarterly) | -433.3% |
| Profit Margin (Quarterly) | -19.17K% |
| Earnings Yield | -33.05% |
| Normalized Earnings Yield | -33.05 |